Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia

Osamu Yokota, Seishi Terada, Hideki Ishizu, Takeshi Ishihara, Hanae Nakashima, Aki Kugo, Kuniaki Tsuchiya, Kenji Ikeda, Toshiyuki Hayabara, Yuko Saito, Shigeo Murayama, Kenji Uéda, Frédéric Checler, Shigetoshi Kuroda

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The pathophysiological basis of cognitive dysfunction, including frontotemporal dementia (FTD), in patients with amyotrophic lateral sclerosis (ALS) and ALS with dementia (ALSD) remains unclear. On the other hand, increased expression of cyclooxygenase-2 (COX-2) in the spinal cord is thought to play a pivotal role in motor neuron degeneration in ALS. In this study, to assess the relationship between the neuronal COX-2 expression in the cerebrum, the formation of tau- and α-synuclein-negative but ubiquitin-positive neuronal inclusions (UPIs), and dementia in motor neuron disease (MND), we examined neuronal COX-2 immunoreactivity in the frontal cortex and hippocampus of patients with non-demented ALS without UPIs (n=11), ALSD with UPIs (n=6), and normal controls (n=24) using a quantitative immunohistochemical technique. Neuronal COX-2 expression in all CA1-4 in the hippocampus was significantly up-regulated in the ALSD group, and, to lesser degree but significantly, in the ALS group. Neuronal COX-2 expression in the frontal cortex was also significantly up-regulated in the ALSD group but not in the ALS group. These findings suggest that (1) the frontal cortex and hippocampus of MND are involved in the same pathogenic process associated with COX-2 induction that has been observed in spinal anterior horn cells, (2) COX-2 induction in the cerebrum is a pathogenic process that can occur even in the absence of UPI formation in MND, and (3) COX-2 expression in the cerebrum may be associated with cognitive dysfunction in MND.

Original languageEnglish
Pages (from-to)399-405
Number of pages7
JournalActa Neuropathologica
Volume107
Issue number5
DOIs
Publication statusPublished - May 2004

Fingerprint

Amyotrophic Lateral Sclerosis
Cyclooxygenase 2
Dementia
Hippocampus
Motor Neuron Disease
Ubiquitin
Cerebrum
Frontal Lobe
Synucleins
Anterior Horn Cells
Frontotemporal Dementia
Nerve Degeneration
Motor Neurons
Spinal Cord

Keywords

  • Amyotrophic lateral sclerosis
  • Cyclooxygenase-2
  • Dementia
  • Frontotemporal dementia
  • Ubiquitin

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia. / Yokota, Osamu; Terada, Seishi; Ishizu, Hideki; Ishihara, Takeshi; Nakashima, Hanae; Kugo, Aki; Tsuchiya, Kuniaki; Ikeda, Kenji; Hayabara, Toshiyuki; Saito, Yuko; Murayama, Shigeo; Uéda, Kenji; Checler, Frédéric; Kuroda, Shigetoshi.

In: Acta Neuropathologica, Vol. 107, No. 5, 05.2004, p. 399-405.

Research output: Contribution to journalArticle

Yokota, O, Terada, S, Ishizu, H, Ishihara, T, Nakashima, H, Kugo, A, Tsuchiya, K, Ikeda, K, Hayabara, T, Saito, Y, Murayama, S, Uéda, K, Checler, F & Kuroda, S 2004, 'Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia', Acta Neuropathologica, vol. 107, no. 5, pp. 399-405. https://doi.org/10.1007/s00401-004-0826-2
Yokota, Osamu ; Terada, Seishi ; Ishizu, Hideki ; Ishihara, Takeshi ; Nakashima, Hanae ; Kugo, Aki ; Tsuchiya, Kuniaki ; Ikeda, Kenji ; Hayabara, Toshiyuki ; Saito, Yuko ; Murayama, Shigeo ; Uéda, Kenji ; Checler, Frédéric ; Kuroda, Shigetoshi. / Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia. In: Acta Neuropathologica. 2004 ; Vol. 107, No. 5. pp. 399-405.
@article{eeff097d2b544243b88f5313574e028b,
title = "Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia",
abstract = "The pathophysiological basis of cognitive dysfunction, including frontotemporal dementia (FTD), in patients with amyotrophic lateral sclerosis (ALS) and ALS with dementia (ALSD) remains unclear. On the other hand, increased expression of cyclooxygenase-2 (COX-2) in the spinal cord is thought to play a pivotal role in motor neuron degeneration in ALS. In this study, to assess the relationship between the neuronal COX-2 expression in the cerebrum, the formation of tau- and α-synuclein-negative but ubiquitin-positive neuronal inclusions (UPIs), and dementia in motor neuron disease (MND), we examined neuronal COX-2 immunoreactivity in the frontal cortex and hippocampus of patients with non-demented ALS without UPIs (n=11), ALSD with UPIs (n=6), and normal controls (n=24) using a quantitative immunohistochemical technique. Neuronal COX-2 expression in all CA1-4 in the hippocampus was significantly up-regulated in the ALSD group, and, to lesser degree but significantly, in the ALS group. Neuronal COX-2 expression in the frontal cortex was also significantly up-regulated in the ALSD group but not in the ALS group. These findings suggest that (1) the frontal cortex and hippocampus of MND are involved in the same pathogenic process associated with COX-2 induction that has been observed in spinal anterior horn cells, (2) COX-2 induction in the cerebrum is a pathogenic process that can occur even in the absence of UPI formation in MND, and (3) COX-2 expression in the cerebrum may be associated with cognitive dysfunction in MND.",
keywords = "Amyotrophic lateral sclerosis, Cyclooxygenase-2, Dementia, Frontotemporal dementia, Ubiquitin",
author = "Osamu Yokota and Seishi Terada and Hideki Ishizu and Takeshi Ishihara and Hanae Nakashima and Aki Kugo and Kuniaki Tsuchiya and Kenji Ikeda and Toshiyuki Hayabara and Yuko Saito and Shigeo Murayama and Kenji U{\'e}da and Fr{\'e}d{\'e}ric Checler and Shigetoshi Kuroda",
year = "2004",
month = "5",
doi = "10.1007/s00401-004-0826-2",
language = "English",
volume = "107",
pages = "399--405",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia

AU - Yokota, Osamu

AU - Terada, Seishi

AU - Ishizu, Hideki

AU - Ishihara, Takeshi

AU - Nakashima, Hanae

AU - Kugo, Aki

AU - Tsuchiya, Kuniaki

AU - Ikeda, Kenji

AU - Hayabara, Toshiyuki

AU - Saito, Yuko

AU - Murayama, Shigeo

AU - Uéda, Kenji

AU - Checler, Frédéric

AU - Kuroda, Shigetoshi

PY - 2004/5

Y1 - 2004/5

N2 - The pathophysiological basis of cognitive dysfunction, including frontotemporal dementia (FTD), in patients with amyotrophic lateral sclerosis (ALS) and ALS with dementia (ALSD) remains unclear. On the other hand, increased expression of cyclooxygenase-2 (COX-2) in the spinal cord is thought to play a pivotal role in motor neuron degeneration in ALS. In this study, to assess the relationship between the neuronal COX-2 expression in the cerebrum, the formation of tau- and α-synuclein-negative but ubiquitin-positive neuronal inclusions (UPIs), and dementia in motor neuron disease (MND), we examined neuronal COX-2 immunoreactivity in the frontal cortex and hippocampus of patients with non-demented ALS without UPIs (n=11), ALSD with UPIs (n=6), and normal controls (n=24) using a quantitative immunohistochemical technique. Neuronal COX-2 expression in all CA1-4 in the hippocampus was significantly up-regulated in the ALSD group, and, to lesser degree but significantly, in the ALS group. Neuronal COX-2 expression in the frontal cortex was also significantly up-regulated in the ALSD group but not in the ALS group. These findings suggest that (1) the frontal cortex and hippocampus of MND are involved in the same pathogenic process associated with COX-2 induction that has been observed in spinal anterior horn cells, (2) COX-2 induction in the cerebrum is a pathogenic process that can occur even in the absence of UPI formation in MND, and (3) COX-2 expression in the cerebrum may be associated with cognitive dysfunction in MND.

AB - The pathophysiological basis of cognitive dysfunction, including frontotemporal dementia (FTD), in patients with amyotrophic lateral sclerosis (ALS) and ALS with dementia (ALSD) remains unclear. On the other hand, increased expression of cyclooxygenase-2 (COX-2) in the spinal cord is thought to play a pivotal role in motor neuron degeneration in ALS. In this study, to assess the relationship between the neuronal COX-2 expression in the cerebrum, the formation of tau- and α-synuclein-negative but ubiquitin-positive neuronal inclusions (UPIs), and dementia in motor neuron disease (MND), we examined neuronal COX-2 immunoreactivity in the frontal cortex and hippocampus of patients with non-demented ALS without UPIs (n=11), ALSD with UPIs (n=6), and normal controls (n=24) using a quantitative immunohistochemical technique. Neuronal COX-2 expression in all CA1-4 in the hippocampus was significantly up-regulated in the ALSD group, and, to lesser degree but significantly, in the ALS group. Neuronal COX-2 expression in the frontal cortex was also significantly up-regulated in the ALSD group but not in the ALS group. These findings suggest that (1) the frontal cortex and hippocampus of MND are involved in the same pathogenic process associated with COX-2 induction that has been observed in spinal anterior horn cells, (2) COX-2 induction in the cerebrum is a pathogenic process that can occur even in the absence of UPI formation in MND, and (3) COX-2 expression in the cerebrum may be associated with cognitive dysfunction in MND.

KW - Amyotrophic lateral sclerosis

KW - Cyclooxygenase-2

KW - Dementia

KW - Frontotemporal dementia

KW - Ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=2342438448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342438448&partnerID=8YFLogxK

U2 - 10.1007/s00401-004-0826-2

DO - 10.1007/s00401-004-0826-2

M3 - Article

C2 - 14991384

AN - SCOPUS:2342438448

VL - 107

SP - 399

EP - 405

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 5

ER -